ESR Cayman Ltd
HKEX:1821
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
ESR Cayman Ltd
HKEX:1821
|
HK |
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
Intel Corp
NASDAQ:INTC
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ESR Cayman Ltd's stock price target?
Not Available
ESR Cayman Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for ESR Cayman Ltd?
Projected CAGR
17%
Over the last 7 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 17%.